Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Consoli, A.
Right arrow Articles by Gerich, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Consoli, A.
Right arrow Articles by Gerich, J.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 38, Issue 5 550-557, Copyright © 1989 by American Diabetes Association


ARTICLES

Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM

A Consoli, N Nurjhan, F Capani and J Gerich
Department of Medicine, University of Pittsburgh, School of Medicine, Pennsylvania.

Excessive hepatic glucose output is an important factor in the fasting hyperglycemia of non-insulin-dependent diabetes mellitus (NIDDM). To determine the relative contributions of gluconeogenesis and glycogenolysis in a quantitative manner, we applied a new isotopic approach, using infusions of [6-3H]glucose and [2-14C]acetate to trace overall hepatic glucose output and phosphoenolpyruvate gluconeogenesis in 14 postabsorptive NIDDM subjects and in 9 nondiabetic volunteers of similar age and weight. Overall hepatic glucose output was increased nearly twofold in the NIDDM subjects (22.7 +/- 1.0 vs. 12.0 +/- 0.6 mumol.kg-1.min-1 in the nondiabetic volunteers, P less than .001); phosphoenolpyruvate gluconeogenesis was increased more than threefold in the NIDDM subjects (12.7 +/- 1.4 vs. 3.6 +/- 0.4 mumol.kg-1.min-1 in the nondiabetic subjects, P less than .001) and was accompanied by increased plasma lactate, alanine, and glucagon concentrations (all P less than .05). The increased phosphoenolpyruvate gluconeogenesis accounted for 89 +/- 6% of the increase in overall hepatic glucose output in the NIDDM subjects and was significantly correlated with the fasting plasma glucose concentrations (r = .67, P less than .01). Glycogenolysis, calculated as the difference between overall hepatic glucose output and phosphoenolpyruvate gluconeogenesis, was not significantly different in the NIDDM subjects (9.9 +/- 0.06 mumol.kg-1.min-1) and the nondiabetic volunteers (8.4 +/- 0.3 mumol.kg-1.min-1). We conclude that increased gluconeogenesis is the predominant mechanism responsible for increased hepatic glucose output in NIDDM.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Visinoni, B. C. Fam, A. Blair, C. Rantzau, B. J. Lamont, R. Bouwman, M. J. Watt, J. Proietto, J. M. Favaloro, and S. Andrikopoulos
Increased glucose production in mice overexpressing human fructose-1,6-bisphosphatase in the liver
Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1132 - E1141.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
I. Quesada, E. Tuduri, C. Ripoll, and A. Nadal
Physiology of the pancreatic {alpha}-cell and glucagon secretion: role in glucose homeostasis and diabetes
J. Endocrinol., October 1, 2008; 199(1): 5 - 19.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. G. Gomez-Valades, A. Mendez-Lucas, A. Vidal-Alabro, F. X. Blasco, M. Chillon, R. Bartrons, J. Bermudez, and J. C. Perales
Pck1 Gene Silencing in the Liver Improves Glycemia Control, Insulin Sensitivity, and Dyslipidemia in db/db Mice
Diabetes, August 1, 2008; 57(8): 2199 - 2210.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. A. Chutkow, P. Patwari, J. Yoshioka, and R. T. Lee
Thioredoxin-interacting Protein (Txnip) Is a Critical Regulator of Hepatic Glucose Production
J. Biol. Chem., January 25, 2008; 283(4): 2397 - 2406.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. E. Dunning and J. E. Gerich
The Role of {alpha}-Cell Dysregulation in Fasting and Postprandial Hyperglycemia in Type 2 Diabetes and Therapeutic Implications
Endocr. Rev., May 1, 2007; 28(3): 253 - 283.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. J. Watkins, D. Platt, T. Papenbrock, A. Wilkins, J. J. Eckert, W. Y. Kwong, C. Osmond, M. Hanson, and T. P. Fleming
From the Cover: Mouse embryo culture induces changes in postnatal phenotype including raised systolic blood pressure
PNAS, March 27, 2007; 104(13): 5449 - 5454.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Gromada, I. Franklin, and C. B. Wollheim
{alpha}-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Endocr. Rev., February 1, 2007; 28(1): 84 - 116.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. D. van Poelje, S. C. Potter, V. C. Chandramouli, B. R. Landau, Q. Dang, and M. D. Erion
Inhibition of Fructose 1,6-Bisphosphatase Reduces Excessive Endogenous Glucose Production and Attenuates Hyperglycemia in Zucker Diabetic Fatty Rats
Diabetes, June 1, 2006; 55(6): 1747 - 1754.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
E. Prodi and S. Obici
Minireview: The Brain as a Molecular Target for Diabetic Therapy
Endocrinology, June 1, 2006; 147(6): 2664 - 2669.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Andreelli, M. Foretz, C. Knauf, P. D. Cani, C. Perrin, M. A. Iglesias, B. Pillot, A. Bado, F. Tronche, G. Mithieux, et al.
Liver Adenosine Monophosphate-Activated Kinase-{alpha}2 Catalytic Subunit Is a Key Target for the Control of Hepatic Glucose Production by Adiponectin and Leptin But Not Insulin
Endocrinology, May 1, 2006; 147(5): 2432 - 2441.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Chevalier, S. C. Burgess, C. R. Malloy, R. Gougeon, E. B. Marliss, and J. A. Morais
The Greater Contribution of Gluconeogenesis to Glucose Production in Obesity Is Related to Increased Whole-Body Protein Catabolism
Diabetes, March 1, 2006; 55(3): 675 - 681.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J.-T. Cheng, C.-C. Huang, I-M. Liu, T.-F. Tzeng, and C. J. Chang
Novel Mechanism for Plasma Glucose-Lowering Action of Metformin in Streptozotocin-Induced Diabetic Rats
Diabetes, March 1, 2006; 55(3): 819 - 825.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Vuguin, E. Raab, B. Liu, N. Barzilai, and R. Simmons
Hepatic Insulin Resistance Precedes the Development of Diabetes in a Model of Intrauterine Growth Retardation
Diabetes, October 1, 2004; 53(10): 2617 - 2622.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
J.-H. Hsu, Y.-C. Wu, S.-S. Liou, I-M. Liu, L.-W. Huang, and J.-T. Cheng
Mediation of Endogenous {beta}-endorphin by Tetrandrine to Lower Plasma Glucose in Streptozotocin-induced Diabetic Rats
Evid. Based Complement. Altern. Med., September 1, 2004; 1(2): 193 - 201.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Gastaldelli, Y. Miyazaki, M. Pettiti, E. Buzzigoli, S. Mahankali, E. Ferrannini, and R. A. DeFronzo
Separate Contribution of Diabetes, Total Fat Mass, and Fat Topography to Glucose Production, Gluconeogenesis, and Glycogenolysis
J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3914 - 3921.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
K. B. Degn, C. B. Juhl, J. Sturis, G. Jakobsen, B. Brock, V. Chandramouli, J. Rungby, B. R. Landau, and O. Schmitz
One Week's Treatment With the Long-Acting Glucagon-Like Peptide 1 Derivative Liraglutide (NN2211) Markedly Improves 24-h Glycemia and {alpha}- and {beta}-Cell Function and Reduces Endogenous Glucose Release in Patients with Type 2 Diabetes
Diabetes, May 1, 2004; 53(5): 1187 - 1194.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
I-M. Liu, W.-C. Chen, and J.-T. Cheng
Mediation of {beta}-Endorphin by Isoferulic Acid to Lower Plasma Glucose in Streptozotocin-Induced Diabetic Rats
J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 1196 - 1204.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
I. E. Peterside, M. A. Selak, and R. A. Simmons
Impaired oxidative phosphorylation in hepatic mitochondria in growth-retarded rats
Am J Physiol Endocrinol Metab, December 1, 2003; 285(6): E1258 - E1266.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Fosgerau, J. Breinholt, J. G. McCormack, and N. Westergaard
Evidence against Glycogen Cycling of Gluconeogenic Substrates in Various Liver Preparations
J. Biol. Chem., August 2, 2002; 277(32): 28648 - 28655.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J.-T. Cheng, I-M. Liu, T.-C. Chi, T.-F. Tzeng, F.-H. Lu, and C. J. Chang
Plasma Glucose-Lowering Effect of Tramadol in Streptozotocin-Induced Diabetic Rats
Diabetes, December 1, 2001; 50(12): 2815 - 2821.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. R. Commerford, M. E. Bizeau, H. McRae, A. Jampolis, J. S. Thresher, and M. J. Pagliassotti
Hyperglycemia compensates for diet-induced insulin resistance in liver and skeletal muscle of rats
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2001; 281(5): R1380 - R1389.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Fosgerau, S. D. Mittelman, A. Sunehag, M. K. Dea, K. Lundgren, and R. N. Bergman
Lack of hepatic "interregulation" during inhibition of glycogenolysis in a canine model
Am J Physiol Endocrinol Metab, August 1, 2001; 281(2): E375 - E383.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
C. M. Avesani, L. Cuppari, A. C. Silva, D. M. Sigulem, M. Cendoroglo, R. Sesso, and S. A. Draibe
Resting energy expenditure in pre-dialysis diabetic patients
Nephrol. Dial. Transplant., March 1, 2001; 16(3): 556 - 565.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Shiota, C. Postic, Y. Fujimoto, T. L. Jetton, K. Dixon, D. Pan, J. Grimsby, J. F. Grippo, M. A. Magnuson, and A. D. Cherrington
Glucokinase Gene Locus Transgenic Mice Are Resistant to the Development of Obesity-Induced Type 2 Diabetes
Diabetes, March 1, 2001; 50(3): 622 - 629.
[Abstract] [Full Text]


Home page
Mol. Cell. Biol.Home page
P. She, M. Shiota, K. D. Shelton, R. Chalkley, C. Postic, and M. A. Magnuson
Phosphoenolpyruvate Carboxykinase Is Necessary for the Integration of Hepatic Energy Metabolism
Mol. Cell. Biol., September 1, 2000; 20(17): 6508 - 6517.
[Abstract] [Full Text]


Home page
JAMAHome page
V. Fonseca, J. Rosenstock, R. Patwardhan, and A. Salzman
Effect of Metformin and Rosiglitazone Combination Therapy in Patients With Type 2 Diabetes Mellitus: A Randomized Controlled Trial
JAMA, April 5, 2000; 283(13): 1695 - 1702.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Balasubramanyam, S. McKay, P. Nadkarni, A. S. Rajan, A. Garza, V. Pavlik, J. A. Herd, F. Jahoor, and P. J. Reeds
Ethnicity affects the postprandial regulation of glycogenolysis
Am J Physiol Endocrinol Metab, November 1, 1999; 277(5): E905 - E914.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. Diraison, V. Large, C. Maugeais, M. Krempf, and M. Beylot
Noninvasive tracing of human liver metabolism: comparison of phenylacetate and apoB-100 to sample glutamine
Am J Physiol Endocrinol Metab, September 1, 1999; 277(3): E529 - E536.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. Q. Siler, R. A. Neese, M. P. Christiansen, and M. K. Hellerstein
The inhibition of gluconeogenesis following alcohol in humans
Am J Physiol Endocrinol Metab, November 1, 1998; 275(5): E897 - E907.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Gao, M. A. Islam, C. M. Brennan, B. E. Dunning, and J. E. Foley
Lactate clamp: a method to measure lactate utilization in vivo
Am J Physiol Endocrinol Metab, October 1, 1998; 275(4): E729 - E733.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. D. Wise, M. F. Nielsen, P. E. Cryer, and R. A. Rizza
Overnight Normalization of Glucose Concentrations Improves Hepatic But Not Extrahepatic Insulin Action in Subjects with Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2461 - 2469.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Holmang, M. Muller, O. K. Andersson, and P. Lonnroth
Minimal influence of blood flow on interstitial glucose and lactate-normal and insulin-resistant muscle
Am J Physiol Endocrinol Metab, March 1, 1998; 274(3): E446 - E452.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. E. Friedman, Y. Sun, T. Ishizuka, C. J. Farrell, S. E. McCormack, L. M. Herron, P. Hakimi, P. Lechner, and J. S. Yun
Phosphoenolpyruvate Carboxykinase (GTP) Gene Transcription and Hyperglycemia Are Regulated by Glucocorticoids in Genetically Obese db/db Transgenic Mice
J. Biol. Chem., December 12, 1997; 272(50): 31475 - 31481.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Wise, M. Nielsen, and R. Rizza
Effects of Hepatic Glycogen Content on Hepatic Insulin Action in Humans: Alteration in the Relative Contributions of Glycogenolysis and Gluconeogenesis to Endogenous Glucose Production
J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1828 - 1833.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. J. Bailey and R. C. Turner
Metformin
N. Engl. J. Med., February 29, 1996; 334(9): 574 - 579.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Gabbay, C. Sutherland, L. Gnudi, B. B. Kahn, R. M. O'Brien, D. K. Granner, and J. S. Flier
Insulin Regulation of Phosphoenolpyruvate Carboxykinase Gene Expression Does Not Require Activation of the Ras/Mitogen-activated Protein Kinase Signaling Pathway
J. Biol. Chem., January 26, 1996; 271(4): 1890 - 1897.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Beylot, M. V. Soloviev, F. David, B. R. Landau, and H. Brunengraber
Tracing Hepatic Gluconeogenesis Relative to Citric Acid Cycle Activity in Vitro and in Vivo
J. Biol. Chem., January 27, 1995; 270(4): 1509 - 1514.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1989 by the American Diabetes Association.